About this medicine
- Approved name
- Intravenous iron-containing medicinal products
- International non-proprietary name (INN) or common name
- ferric carboxymaltose
- iron dextran
- sodium ferric gluconate
- iron isomaltoside
- iron sucrose
- Class
- -
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-31/1322
- Type
- Article 31 referrals
This type of referral is triggered when the interest of the Union is involved, following concerns relating to the quality, safety or efficacy of a medicine or a class of medicines.
- Decision making model
- CHMP-EC
Key dates and outcomes
- CHMP opinion date
- 27/06/2013
- EC decision date
- 13/09/2013